Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall zyprexaZyprexa is Eli Lilly and Co.''s best selling drug, accounting for half of Lilly''s profit. In 2003 alone, Zyprexa had global sales of $4.3 billion. The schizophrenia treatment was introduced to the market in 1996 as an alternative to older treatments that are normally associated to serious side effects.
Although drugmakers are not allowed to market their products for uses that the drug has not been approved for, doctors are able to legally prescribe them. Zyprexa abuse can cause dangerous and deadly side effects and doctors have been criticized for routinely prescribing the drug to treat symptoms of dementia, which Zyprexa has not been approved for. In March 2004, Lilly indicated Zyprexa might come under federal investigation.
Lilly was already under investigation for its promotion of an osteoporosis drug when it learned a new probe would probably occur for Zyprexa and Prozac. The investigation on Lilly''s marketing practices could mean that Zyprexa abuse because of false promotions could have occurred. Zyprexa has been prescribed to 12.5 million people since its entrance to the market.
On March 6, 2008, the State of Alaska provided its opening arguments in a lawsuit against the maker of the schizophrenia drug Zyprexa.
The lawsuit contends that the pharmaceutical giant Eli Lilly played down the diabetes and weight gain The maker of the popular antipsychotic drug Zyprexa is in talks to settle state and federal claims over the company’s marketing practices for more than $1 billion, potentially the... Strong new warnings were added to the label of the top-selling antipsychotic Zyprexa last week, alerting patients and physicians to the increased risk of high blood sugar and » Read More "Makers of Zyprexa may Settle Suit"
"High Blood Sugar and Weight Gain Risks"